NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR)
CUSIP: 640268108
Q3 2017 13F Holders as of 30 Sep 2017
- Type / Class
- Equity / Common Stock, $0.0001 par value
- Shares outstanding
- 28,811,441
- Total 13F shares
- 153,912,042
- Share change
- +2,557,753
- Total reported value
- $3,692,685,792
- Put/Call ratio
- 26%
- Price per share
- $24.00
- Number of holders
- 203
- Value change
- +$66,532,732
- Number of buys
- 104
- Number of sells
- 75
Quarterly Holders Quick Answers
What is CUSIP 640268108?
CUSIP 640268108 identifies NKTR - NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 640268108:
Top shareholders of NKTR - NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| OppenheimerFunds, Inc. |
13F
|
Company |
88%
|
25,257,221
|
$493,779,000 | — | 30 Jun 2017 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
80%
|
23,122,286
|
$452,041,000 | — | 30 Jun 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
70%
|
20,221,479
|
$395,330,000 | — | 30 Jun 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
49%
|
14,009,894
|
$273,893,000 | — | 30 Jun 2017 | |
| Camber Capital Management LP |
13F
|
Company |
19%
|
5,350,000
|
$104,593,000 | — | 30 Jun 2017 | |
| STATE STREET CORP |
13F
|
Company |
15%
|
4,408,270
|
$86,179,000 | — | 30 Jun 2017 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
13%
|
3,773,983
|
$73,781,000 | — | 30 Jun 2017 | |
| Invesco Ltd. |
13F
|
Company |
13%
|
3,614,045
|
$70,655,000 | — | 30 Jun 2017 | |
| BRIDGER MANAGEMENT, LLC |
13F
|
Company |
9.8%
|
2,811,092
|
$54,957,000 | — | 30 Jun 2017 | |
| NORGES BANK |
13F
|
Company |
9.4%
|
2,713,717
|
$53,053,000 | — | 30 Jun 2017 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
7.8%
|
2,253,793
|
$44,062,000 | — | 30 Jun 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
7.4%
|
2,138,632
|
$41,812,000 | — | 30 Jun 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
6.7%
|
1,937,352
|
$37,877,000 | — | 30 Jun 2017 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
6.2%
|
1,772,929
|
$34,661,000 | — | 30 Jun 2017 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
6%
|
1,733,110
|
$33,882,000 | — | 30 Jun 2017 | |
| PointState Capital LP |
13F
|
Company |
6%
|
1,731,000
|
$33,841,000 | — | 30 Jun 2017 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
5.3%
|
1,529,950
|
$29,910,000 | — | 30 Jun 2017 | |
| Artal Group S.A. |
13F
|
Company |
4.9%
|
1,400,000
|
$27,370,000 | — | 30 Jun 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
4.8%
|
1,380,357
|
$26,985,000 | — | 30 Jun 2017 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
4.5%
|
1,289,717
|
$25,214,000 | — | 30 Jun 2017 | |
| Duquesne Family Office LLC |
13F
|
Company |
4%
|
1,166,100
|
$22,797,000 | — | 30 Jun 2017 | |
| ROTHSCHILD & CO ASSET MANAGEMENT US INC. |
13F
|
Company |
3.9%
|
1,125,750
|
$22,008,000 | — | 30 Jun 2017 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
3.8%
|
1,099,000
|
$21,485,000 | — | 30 Jun 2017 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
3.5%
|
999,525
|
$19,541,000 | — | 30 Jun 2017 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
3.3%
|
952,443
|
$18,620,000 | — | 30 Jun 2017 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
3%
|
859,945
|
$16,812,000 | — | 30 Jun 2017 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
2.8%
|
799,338
|
$15,627,000 | — | 30 Jun 2017 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
2.8%
|
795,000
|
$15,542,000 | — | 30 Jun 2017 | |
| SYSTEMATIC FINANCIAL MANAGEMENT LP |
13F
|
Company |
2.5%
|
733,030
|
$14,331,000 | — | 30 Jun 2017 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
2.4%
|
686,586
|
$13,423,000 | — | 30 Jun 2017 | |
| PDT Partners, LLC |
13F
|
Company |
2.3%
|
664,500
|
$12,991,000 | — | 30 Jun 2017 | |
| MORGAN STANLEY |
13F
|
Company |
2.3%
|
662,347
|
$12,948,000 | — | 30 Jun 2017 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
2.3%
|
654,847
|
$12,803,000 | — | 30 Jun 2017 | |
| Tamarack Advisers, LP |
13F
|
Company |
2%
|
590,000
|
$11,535,000 | — | 30 Jun 2017 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
2%
|
575,108
|
$11,243,000 | — | 30 Jun 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
1.8%
|
518,343
|
$10,131,000 | — | 30 Jun 2017 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
1.8%
|
511,013
|
$9,990,000 | — | 30 Jun 2017 | |
| FMR LLC |
13F
|
Company |
1.7%
|
493,703
|
$9,652,000 | — | 30 Jun 2017 | |
| First Light Asset Management, LLC |
13F
|
Company |
1.6%
|
470,194
|
$9,192,000 | — | 30 Jun 2017 | |
| Granahan Investment Management, LLC |
13F
|
Company |
1.6%
|
459,201
|
$8,977,000 | — | 30 Jun 2017 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
1.6%
|
458,997
|
$8,973,000 | — | 30 Jun 2017 | |
| Numeric Investors LLC |
13F
|
Company |
1.5%
|
440,729
|
$8,616,000 | — | 30 Jun 2017 | |
| J. Goldman & Co LP |
13F
|
Company |
1.4%
|
414,800
|
$8,109,000 | — | 30 Jun 2017 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.4%
|
403,574
|
$7,890,000 | — | 30 Jun 2017 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
1.2%
|
355,297
|
$6,946,000 | — | 30 Jun 2017 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
1.2%
|
332,609
|
$6,503,000 | — | 30 Jun 2017 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
1.1%
|
322,257
|
$6,300,000 | — | 30 Jun 2017 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
1.1%
|
321,213
|
$6,280,000 | — | 30 Jun 2017 | |
| SEI INVESTMENTS CO |
13F
|
Company |
1.1%
|
319,353
|
$6,243,000 | — | 30 Jun 2017 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
1.1%
|
309,917
|
$6,058,878 | — | 30 Jun 2017 |
Institutional Holders of NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR) as of Q3 2017
As of 30 Sep 2017,
NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR) was held by
203 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
153,912,042 shares.
The largest 10 holders included
OppenheimerFunds, Inc., PRIMECAP MANAGEMENT CO/CA/, BlackRock Inc., VANGUARD GROUP INC, Camber Capital Management LLC, STATE STREET CORP, WESTFIELD CAPITAL MANAGEMENT CO LP, Invesco Ltd., JANUS HENDERSON GROUP PLC, and NORGES BANK.
This page lists
203
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2017 vs Q2 2017 Across Filers
Q2 2017 holders
196
Q3 2017 holders
203
Holder diff
7
| Investor | Q2 2017 Shares | Q3 2017 Shares | Share Diff | Share Chg % | Q2 2017 Value $ | Q3 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.